Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
182K
-
Shares change
-
-2.8K
-
Total reported value, excl. options
-
$150K
-
Value change
-
-$16.2K
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$0.83
Significant Holders of Predictive Oncology Inc. - COM (POAI) as of Q2 2025
15 filings reported holding POAI - Predictive Oncology Inc. - COM as of Q2 2025.
Predictive Oncology Inc. - COM (POAI) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 182K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (71.3K shares), GEODE CAPITAL MANAGEMENT, LLC (63.2K shares), Virtu Financial LLC (16.2K shares), STATE STREET CORP (13.8K shares), CARNEGIE MELLON UNIVERSITY (10.4K shares), RAYMOND JAMES FINANCIAL INC (3.87K shares), Tower Research Capital LLC (TRC) (1.5K shares), WELLS FARGO & COMPANY/MN (1K shares), OSAIC HOLDINGS, INC. (425 shares), and BANK OF AMERICA CORP /DE/ (80 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.